Advanced search
Publication Cover
Autoimmunity Volume 35, 2002 - Issue 7
Submit an article Journal homepage
15
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Autoantibodies Directed Against Ribosomal Proteins in Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Comparative Study

A. Desbos Laboratoire d'Immunologie, Centre Hospitalier Lyon-Sud (Hospices Civils de Lyon), Chemin du Grand Revoyet, 69495 Pierre-Bénite cedex, France
,
P. Gonzalo Laboratoire de Biochimie Médicale, Institut de Biologie et Chimie des Protéines (Centre National de la Recherche Scientifique), Lyon, France
,
J.C. Monier Laboratoire d'Immunologie, Centre Hospitalier Lyon-Sud (Hospices Civils de Lyon), Chemin du Grand Revoyet, 69495 Pierre-Bénite cedex, France
,
J. Tebib Service de Rhumatologie, Centre Hospitalier Lyon-Sud (Hospices Civils de Lyon), Pierre-Bénite, France
,
J.P. Reboud Laboratoire de Biochimie Médicale, Institut de Biologie et Chimie des Protéines (Centre National de la Recherche Scientifique), Lyon, France
,
H. Perrier Laboratoire de Biochimie Pharmaceutique, Faculté Rockefeller, Lyon, France
,
J. Bienvenu Laboratoire d'Immunologie, Centre Hospitalier Lyon-Sud (Hospices Civils de Lyon), Chemin du Grand Revoyet, 69495 Pierre-Bénite cedex, France
&
N. Fabien Laboratoire d'Immunologie, Centre Hospitalier Lyon-Sud (Hospices Civils de Lyon), Chemin du Grand Revoyet, 69495 Pierre-Bénite cedex, France
 show all
Pages 427-434 | Published online: 07 Jul 2009

  • Chapman, R.W.G., Arborgh, B.A.M., Rhodes, J.M., Summerfield, J.A., Dick, R., Scheuer, P.J. and Sherlock, S. (1980) "Primary sclerosing cholangitis: a review of its clinical features, cholangiography and hepatic histology", Gut 21, 870-877.
  • Lee, Y.M. and Kaplan, M.M. (1995) "Primary sclerosing cholangitis", N. Engl. J. Med. 332, 924-933.
  • Ludwig, J., Barham, S.S., LaRusso, N.F., Elveback, L.R., Wiesner, R.H. and McCall, J.T. (1981) "Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis", Hepatology 1, 632-640.
  • Bodenheimer, H.C., LaRusso, N.F., Thayer, W.R., Charland, C., Staples, P.J. and Ludwig, J. (1983) "Elevated circulating immune complexes in primary sclerosing cholangitis", Hepatology 3, 150-154.
  • Brinch, T., Teisberg, P., Schrumpf, E. and Akessom, I. (1982) "The in vivo metabolism of C3 in hepatobiliary disease associated with ulcerative colitis", Scand. J. Gastroenterol. 17, 523-527.
  • Senaldi, G., Donaldson, P.T., Magrin, S., Farrant, J.M., Alexander, G.J.M., Vergani, D. and Williams, R. (1989) "Activation of the complement system in primary sclerosing cholangitis", Gastroenterology 97, 1430-1434.
  • Chapman, R.W.G., Cottone, M., Selby, W.S., Shepherd, H.A., Sherlock, S. and Jewell, D.P. (1986) "Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis", Gut 27, 86-91.
  • Schrumpf, E., Fausa, O., Forre, O., Dobloug, J.H., Ritland, S. and Thorsby, E. (1982) "HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease", Scand. J. Gastroenterol. 17, 187-191.
  • Chapman, R.W., Varghese, Z., Gaul, R., Patel, G., Kokinon, N. and Sherlock, S. (1983) "Association of primary sclerosing cholangitis with HLA-B8", Gut 24, 38-41.
  • Shepherd, H.A., Selby, W.S., Chapman, R.W.G., Nolan, D., Barbatis, C., McGee, J.O'D. and Jewell, D.P. (1983) "Ulcerative colitis and persistent liver dysfunction", Q. J. Med. 52, 503-513.
  • Prochazka, E.J., Terasaki, P.I., Park, M.S., Goldstein, L.I. and Busuttil, R.W. (1990) "Association of primary sclerosing cholangitis with HLA DRw52a", N. Engl. J. Med. 322, 1842-1844.
  • Donaldson, P.T., Farrant, J.M., Wilkinson, M.L., Hayllar, K., Portmann, B.C. andWilliams, R. (1991b) "Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis", Hepatology 13, 129-133.
  • Farrant, J.M., Doherty, D.G., Donaldson, P.T., Vaughan, R.W., Hayllar, K.M., Welsh, K.I., Eddleston, A.L.W.F. and Williams, R. (1992) "Amino acid substitutions at position 38 of the DRb polypeptide confer susceptibility and protection from primary sclerosing cholangitis", Hepatology 16, 390-395.
  • Mehal, W.Z., Lo, Y-M.D., Wordsworth, B.P., Neuberger, J.M., Hubscher, S.C., Fleming, K.A. and Chapman, R.W. (1994) "HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis", Gastroenterology 106, 160-167.
  • Olerup, O., Olsson, R., Hultcrantz, R. and Broome, U. (1995) "HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis", Gastroenterology 108, 870-878.
  • Spurkland, A., Saarinen, S., Boberg, K.M., Mitchell, S., Broome, U., Caballeria, L., Ciusani, E., Chapman, R., Ercilla, G., Fausa, O., Knutsen, I., Pares, A., Rosina, F., Olerup, O., Thorsby, E. and Schrumpf, E. (1999) "HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations", Tissue Antigens 53, 459-469.
  • Chapman, R.W.G. and Does, H.L.A. (1995) "status influence prognosis in primary sclerosing cholangitis", Gastroenterology 108, 937-940.
  • Moloney, M.M., Thomson, L.J., Strettell, M.J., Williams, R. and Donaldson, P.T. (1998) "HLA-C genes and susceptibility to primary sclerosing cholangitis", Hepatology 28, 660-662.
  • Bernal, W., Moloney, M., Underhill, J. and Donaldson, P.T. (1999) "Association of tumour necrosis factor polymorphism with primary sclerosing cholangitis", J. Hepatol. 30, 237-241.
  • Mitchell, S.A., Grove, J., Spurkland, A., Boberg, K.M., Fleming, K.A., Day, C.P., Schrumpf, E. and Chapman, R.W. (2001) "Association of the tumour necrosis factor a-308 but not the interleukin 10 - 627promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis", Gut 49, 288-294.
  • Norris, S., Kondeatis, E., Collins, R., Satsangi, J., Clare, M., Chapman, R., Stephens, H., Harrison, P., Vaughan, R. and Donaldson, P. (2001) "Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism", Gastroenterology 120, 1475-1482.
  • Wiencke, K., Spurkland, A., Schrumpf, E. and Boberg, K.M. (2001) "Primary sclerosing cholangitis is associated to an extended B8- DR3 haplotype including particular MICA and MICB alleles", Hepatology 34, 625-630.
  • Donaldson, P.T. and Czaja, A.J. (2000) "HLA DRB1 valine/ glycine-86 dimorphism versus lysine-71 as primary MHC encoded susceptibility determinants in primary sclerosing cholangitis and type 1 autoimmune hepatitis: a study of 448 adult patients", Hepatology 32, 301A, [Abstract No. 565].
  • Donaldson, P.T., Constantini, P.K., Underhill, J. and Harrison, P.M. (1998) "Remodelling the HLA associations with primary sclerosing cholangitis: Novel association with phenylalanine at position 87 on DQb-polypeptide", Hepatology 28, 403A, [Abstract No. 964].
  • Wiesner, R.H. and LaRusso, N.F. (1980) "Clinicopathological features of the syndrome of primary sclerosing cholangitis", Gastroenterology 79, 200-206.
  • Strettell, M.J.D., Donaldson, P.T., Thompson, L.J., Santrach, P.J., Breanndan-Moore, S., Williams, R., Czaja, A.J., "Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis". Gastroenterology, 112 pp. 2028-2035.
  • Olerup, O. and Zetterquist, H. (1992) "HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation", Tissue Antigens 39, 225-235.
  • Doherty, D.G., Vaughan, R.W., Donaldson, P.T. and Mowat, A.P. (1992) "HLA DQA, DQB, and DRB genotyping by oligonucleotide analysis: Distribution of alleles and haplotypes in British Caucasoids", Hum. Immunol. 34, 53-63.
  • Svejgaard, A. and Ryder, L.P. (1994) "HLA and disease associations: detecting the strongest association", Tissue Antigens 43, 18-27.
  • Dixon, W.J. (1985) BMDP statistical software (UCLA Press, Berkeley, CA).
  • Marsh, S.G.E. (1998) "HLA class II region sequences", Tissue Antigens 51, 467-507.
  • Boberg, K.M., Spurkland, A., Rocca, G., Egeland Saarinen, S., Mitchell, S., Broome, U., Chapman, R., Olerup, O., Pares, A., Rosina, F. and Scrumpf, E. (2001) "The HLA-DR3, DQ2 heterozygous genotype is associated with an accelerated progression in primary sclerosing cholangitis", Scand. J. Gastroenterol. 36, 886-890.
  • Gow, P.J., Flemming, K.A. and Chapman, R.W. (2000) "Primary sclerosing cholangitis associated with rheumatoid arthritis and DR4: is the association a marker of patients with progressive liver disease", J. Hepatol. 34, 631-635.
  • Stokkers, P.C.F., Reitsma, P.H., Tytgat, G.N.J. and van Deventer, S.J.H. (1999) "HLA-DR and-DQ phenotypes in inflammatory bowel disease: a meta analysis", Gut 45, 395-401.
  • Nepom, G.T. (1990) "A unified hypothesis for the complex genetics of HLA associations with IDDM", Diabetes 39, 1153-1157.
  • Sheehy, M.J. (1992) "HLA and insulin-dependent diabetes: a protective perspective", Diabetes 41, 123-129.
  • Pando, M., Lariba, J., Fernadez, G.C., Fainboim, H., Ciocca, M., Ramonet, M., Badia, I., Daruich, J., Findor, J., Tanno, H., Canero-Velasco, C. and Fainboim, L. (1999) "Paediatric and adult forms of type 1 autoimmune hepatitis in Argentina: evidence for differential genetic predisposition", Hepatology 30, 1374-1380.
  • Sollid, L.M. and Thorsby, E. (1993) "The primary association of celiac disease to a given DQ a/b heterodimer explains the divergent HLA-DR associations observed in Caucasian populations", Tissue Antigens 36, 136-137.
  • Todd, J.A., Bell, J.I. and McDevitt, H.O. (1987) "HLA-DQb gene contributes to susceptibility and resistance in insulin-dependent diabetes mellitus", Nature 329, 599-604.
  • Nepom, G.T. (2000) "HLA and type 1 diabetes", In: Warrens, A. and Lechler, R., eds, HLA in health and disease (Academic Press, London), pp. 231-237.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.